Oncology Research
36 comprehensive market analysis studies and research reports on the Oncology sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 216 companies, enriched with industry statistics, insights, and a lot more.

TRENDING REPORTS
Prostate Cancer Market
CAGR: 8.29%
Study Period: 2020 - 2031
MEA Uterine Cancer Therapeutics & Diagnostics Market
CAGR: 5.7%
Study Period: 2019 - 2030
Asia-Pacific Pancreatic Cancer Therapeutics & Diagnostics Market
CAGR: 6.40%
Study Period: 2019 - 2030
Asia-Pacific Bladder Cancer Therapeutics and Diagnostics Market
CAGR: 5%
Study Period: 2019 - 2030
Europe Kidney Cancer Therapeutics & Diagnostics Market
CAGR: 5.7%
Study Period: 2019 - 2030
Healthcare
Categories
36 Healthcare Reports
Categories
Filters and Sort
Showing 30 of 36 results in Oncology
Pituitary Cancer Market
CAGR: 9.21%
Study Period: 2020 - 2031
Starting at:$4,750
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:Novartis, Pfizer, Ipsen, Recordati S.p.A., Camurus AB
Starting at:$4,750
Soft Tissue Sarcoma Market
CAGR: 8.75%
Study Period: 2020 - 2031
Starting at:$4,750
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:Roche, Novartis, Bayer, Pfizer, Merck
Starting at:$4,750
United States Melanoma Diagnostics and Therapeutics Market
CAGR: 8.66%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: United States
Major Players:Amgen, Bristol-Myers Squibb, Roche, Merck, GlaxoSmithKline
Starting at:$4,750
Prostate Health Market
CAGR: 9.18%
Study Period: 2020 - 2031
Starting at:$4,750
Regions Covered: North America, Europe, Asia Pacific, South America, Middle East and Africa
Major Players:Teleflex, Novartis, Elekta, Siemens Healthineers, Bayer
Starting at:$4,750
South America Bladder Cancer Therapeutics and Diagnostics Market
CAGR: 3%
Study Period: 2019 - 2030
Starting at:$4,750
Countries Covered: Brazil, Argentina, South America
Major Players:Pfizer, Johnson & Johnson, AstraZeneca, Bristol-Myers Squibb, Merck
Starting at:$4,750
Europe Bladder Cancer Therapeutics and Diagnostics Market
CAGR: 5%
Study Period: 2019 - 2030
Starting at:$4,750
Countries Covered: Germany, United Kingdom, France, Italy, Spain, Europe
Major Players:Roche, Bristol-Myers Squibb Company, AstraZeneca, Johnson & Johnson, Endo International
Starting at:$4,750
North America Uterine Cancer Therapeutics and Diagnostics Market
CAGR: 4.18%
Study Period: 2020 - 2031
Starting at:$4,750
Countries Covered: United States, Canada, Mexico, North America
Major Players:Abbvie, Merck, Pfizer, Beckton Dickinson, Bristol-Myers Squibb
Starting at:$4,750
Cervical Cancer Diagnostics And Therapeutics Market
CAGR: 5.37%
Study Period: 2020 - 2031
Starting at:$4,750
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:Novartis, Beckton Dickinson, Abbott Laboratories, Roche, GlaxoSmithKline
Starting at:$4,750
Global Melanoma Diagnostics and Therapeutics Market
CAGR: 15.1%
Study Period: 2019 - 2030
Starting at:$4,750
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:Abbott Laboratories, Amgen, Bristol-Myers Squibb, Novartis, Roche
Starting at:$4,750
Europe Ovarian Cancer Diagnostics and Therapeutics Market
CAGR: 8.6%
Study Period: 2019 - 2030
Starting at:$4,750
Countries Covered: Germany, United Kingdom, France, Italy, Spain, Europe
Major Players:Roche, Siemens Healthineers, Johnson & Johnson, Eli Lilly and Company, GlaxoSmithKline
Starting at:$4,750
North America Kidney Cancer Therapeutics & Diagnostics Market
CAGR: 5.8%
Study Period: 2019 - 2030
Starting at:$4,750
Countries Covered: United States, Canada, Mexico, North America
Major Players:Pfizer, Roche, Bayer, Novartis, Amgen
Starting at:$4,750
MEA Bladder Cancer Therapeutics & Diagnostics Market
CAGR: 5.6%
Study Period: 2019 - 2030
Starting at:$4,750
Countries Covered: South Africa, Middle East and Africa
Major Players:Pfizer, Johnson & Johnson, AstraZeneca, Bristol-Myers Squibb, Merck
Starting at:$4,750
North America Bladder Cancer Therapeutics and Diagnostics Market
CAGR: 5%
Study Period: 2019 - 2030
Starting at:$4,750
Countries Covered: United States, Canada, Mexico, North America
Major Players:Bristol-Myers Squibb Company, AstraZeneca, GlaxoSmithKline, Johnson & Johnson, Roche
Starting at:$4,750
Kidney Cancer Therapeutics and Diagnostics Market
CAGR: 4.86%
Study Period: 2021 - 2030
Starting at:$4,750
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:Amgen, Bayer, Roche, Bristol-Myers Squibb, Abbott Laboratories
Starting at:$4,750
Asia Pacific Liver Cancer Market
CAGR: 5.2%
Study Period: 2019 - 2030
Starting at:$4,750
Countries Covered: China, Japan, India, Australia, South Korea, Asia
Major Players:Abbott Laboratories, Roche, Boston Scientific, Bayer, Siemens Healthineers
Starting at:$4,750
Middle East and Africa Kidney Cancer Therapeutics & Diagnostics Market
CAGR: 5.2%
Study Period: 2021 - 2030
Starting at:$4,750
Countries Covered: Saudi Arabia, United Arab Emirates, South Africa, Middle East and Africa
Major Players:Bayer, Roche, Bristol-Myers Squibb, Abbott Laboratories, Amgen
Starting at:$4,750
Latin America Melanoma Diagnostics and Therapeutics Market
CAGR: 13.8%
Study Period: 2021 - 2030
Starting at:$4,750
Countries Covered: Brazil, Argentina, Mexico, Latin America
Major Players:Abbott Laboratories, Amgen, Roche, GlaxoSmithKline, Novartis
Starting at:$4,750
South America Kidney Cancer Therapeutics & Diagnostics Market
CAGR: 6.5%
Study Period: 2019 - 2030
Starting at:$4,750
Countries Covered: Brazil, Argentina, South America
Major Players:Eisai, Bristol-Myers Squibb, Exelixis, Novartis, Bayer
Starting at:$4,750
Radiotherapy Market
CAGR: 7.08%
Study Period: 2020 - 2031
Starting at:$4,750
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:GE Healthcare, Accuray, Siemens Healthineers, IsoRay, Elekta
Starting at:$4,750
South America Ovarian Cancer Diagnostics And Therapeutics Market
CAGR: 9.22%
Study Period: 2020 - 2031
Starting at:$4,750
Countries Covered: Brazil, Argentina, Colombia, Chile, Peru, South America
Major Players:AstraZeneca, Roche, Siemens Healthineers, Johnson & Johnson, GlaxoSmithKline
Starting at:$4,750
Pancreatic Cancer Therapeutics And Diagnostics Market
CAGR: 7.08%
Study Period: 2020 - 2031
Starting at:$4,750
Regions Covered: North America, Europe, Asia Pacific, South America, Middle East and Africa
Major Players:Myriad Genetics, Pfizer, Novartis, AstraZeneca, Immunovia
Starting at:$4,750
APAC Uterine Cancer Therapeutics & Diagnostics Market
CAGR: 2.5%
Study Period: 2019 - 2030
Starting at:$4,750
Countries Covered: China, Japan, India, Australia, South Korea, Asia
Major Players:Merck, Eisai, Abbott Laboratories, Roche, Takeda Pharmaceuticals
Starting at:$4,750
Asia-Pacific Kidney Cancer Therapeutics & Diagnostics Market
CAGR: 4.1%
Study Period: 2019 - 2030
Starting at:$4,750
Countries Covered: China, Japan, India, Australia, South Korea, Asia
Major Players:Pfizer, Roche, Bayer, Novartis, Eisai
Starting at:$4,750
APAC Ovarian Cancer Diagnostics & Therapeutics Market
CAGR: 15.10%
Study Period: 2019 - 2030
Starting at:$4,750
Countries Covered: China, Japan, India, Australia, South Korea, Asia
Major Players:Eli Lilly and Company, Bristol-Myers Squibb, Roche, AstraZeneca, GlaxoSmithKline
Starting at:$4,750
Colorectal Cancer Diagnostics And Therapeutics Market
CAGR: 4.89%
Study Period: 2020 - 2031
Starting at:$4,750
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:Epigenomics, Abbott Laboratories, Roche, Novigenix, Amgen
Starting at:$4,750
Middle East & Africa Ovarian Cancer Diagnostics And Therapeutics Market
CAGR: 7.90%
Study Period: 2019 - 2030
Starting at:$4,750
Countries Covered: South Africa, Middle East and Africa
Major Players:AstraZeneca, Bristol-Myers Squibb, Roche, Johnson & Johnson, Siemens Healthineers
Starting at:$4,750
Latin America Pancreatic Cancer Therapeutics And Diagnostics Market
CAGR: 5.43%
Study Period: 2020 - 2031
Starting at:$4,750
Countries Covered: Brazil, Mexico, Argentina, South America
Major Players:Bristol-Myers Squibb, Novartis, Roche, Pfizer, Eli Lilly and Company
Starting at:$4,750
Ovarian Cancer Diagnostics and Therapeutics Market
CAGR: 9.5%
Study Period: 2021 - 2030
Starting at:$4,750
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:AstraZeneca, GlaxoSmithKline, Johnson & Johnson, Roche, Siemens Healthineers
Starting at:$4,750
Uterine Cancer Therapeutics And Diagnostics Market
CAGR: 6.26%
Study Period: 2020 - 2031
Starting at:$4,750
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:Abbott Laboratories, Beckton Dickinson, Merck, Roche, GlaxoSmithKline
Starting at:$4,750
Bladder Cancer Therapeutics And Diagnostics Market
CAGR: 6.12%
Study Period: 2020 - 2031
Starting at:$4,750
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:Bristol-Myers Squibb Company, GlaxoSmithKline, Merck, Johnson & Johnson, Roche
Starting at:$4,750
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.





























